These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
434 related items for PubMed ID: 17169604
1. Possibility of membrane modification as a mechanism of antimony resistance in Leishmania donovani. Kothari H, Kumar P, Sundar S, Singh N. Parasitol Int; 2007 Mar; 56(1):77-80. PubMed ID: 17169604 [Abstract] [Full Text] [Related]
2. Assessing aquaglyceroporin gene status and expression profile in antimony-susceptible and -resistant clinical isolates of Leishmania donovani from India. Mandal S, Maharjan M, Singh S, Chatterjee M, Madhubala R. J Antimicrob Chemother; 2010 Mar; 65(3):496-507. PubMed ID: 20067981 [Abstract] [Full Text] [Related]
3. Novel mechanism of drug resistance in kala azar field isolates. Singh N, Singh RT, Sundar S. J Infect Dis; 2003 Aug 15; 188(4):600-7. PubMed ID: 12898450 [Abstract] [Full Text] [Related]
4. Role of aquaglyceroporin (AQP1) gene and drug uptake in antimony-resistant clinical isolates of Leishmania donovani. Maharjan M, Singh S, Chatterjee M, Madhubala R. Am J Trop Med Hyg; 2008 Jul 15; 79(1):69-75. PubMed ID: 18606765 [Abstract] [Full Text] [Related]
5. Proteophosphoglycan is differentially expressed in sodium stibogluconate-sensitive and resistant Indian clinical isolates of Leishmania donovani. Samant M, Sahasrabuddhe AA, Singh N, Gupta SK, Sundar S, Dube A. Parasitology; 2007 Aug 15; 134(Pt 9):1175-84. PubMed ID: 17362540 [Abstract] [Full Text] [Related]
6. Characterization of natural antimony resistance in Leishmania donovani isolates. Mittal MK, Rai S, Ashutosh, Ravinder, Gupta S, Sundar S, Goyal N. Am J Trop Med Hyg; 2007 Apr 15; 76(4):681-8. PubMed ID: 17426170 [Abstract] [Full Text] [Related]
7. Characterisation of antimony-resistant Leishmania donovani isolates: biochemical and biophysical studies and interaction with host cells. Mukhopadhyay R, Mukherjee S, Mukherjee B, Naskar K, Mondal D, Decuypere S, Ostyn B, Prajapati VK, Sundar S, Dujardin JC, Roy S. Int J Parasitol; 2011 Nov 15; 41(13-14):1311-21. PubMed ID: 21920365 [Abstract] [Full Text] [Related]
8. Molecular Preadaptation to Antimony Resistance in Leishmania donovani on the Indian Subcontinent. Dumetz F, Cuypers B, Imamura H, Zander D, D'Haenens E, Maes I, Domagalska MA, Clos J, Dujardin JC, De Muylder G. mSphere; 2018 Apr 25; 3(2):. PubMed ID: 29669889 [Abstract] [Full Text] [Related]
9. The overexpression of genes of thiol metabolism contribute to drug resistance in clinical isolates of visceral leishmaniasis (kala azar) in India. Singh N, Chatterjee M, Sundar S. Parasit Vectors; 2014 Dec 17; 7():596. PubMed ID: 25515494 [Abstract] [Full Text] [Related]
10. Differential expression of proteins in antimony-susceptible and -resistant isolates of Leishmania donovani. Biyani N, Singh AK, Mandal S, Chawla B, Madhubala R. Mol Biochem Parasitol; 2011 Oct 17; 179(2):91-9. PubMed ID: 21736901 [Abstract] [Full Text] [Related]
11. Studies on stibanate resistant Leishmania donovani isolates of Indian origin. Pal S, Mandal A, Duttagupta S. Indian J Exp Biol; 2001 Mar 17; 39(3):249-54. PubMed ID: 11495284 [Abstract] [Full Text] [Related]
12. Prokaryotic expression, purification, and polyclonal antibody production against a novel drug resistance gene of Leishmania donovani clinical isolate. Kothari H, Kumar P, Singh N. Protein Expr Purif; 2006 Jan 17; 45(1):15-21. PubMed ID: 16289919 [Abstract] [Full Text] [Related]
13. Overexpression of histone H2A modulates drug susceptibility in Leishmania parasites. Singh R, Kumar D, Duncan RC, Nakhasi HL, Salotra P. Int J Antimicrob Agents; 2010 Jul 17; 36(1):50-7. PubMed ID: 20427152 [Abstract] [Full Text] [Related]
14. Over-Expression of Cysteine Leucine Rich Protein Is Related to SAG Resistance in Clinical Isolates of Leishmania donovani. Das S, Shah P, Tandon R, Yadav NK, Sahasrabuddhe AA, Sundar S, Siddiqi MI, Dube A. PLoS Negl Trop Dis; 2015 Aug 17; 9(8):e0003992. PubMed ID: 26295340 [Abstract] [Full Text] [Related]
15. Increased parasite surface antigen-2 expression in clinical isolates of Leishmania donovani augments antimony resistance. Bhandari V, Kumar D, Verma S, Srividya G, Negi NS, Singh R, Salotra P. Biochem Biophys Res Commun; 2013 Nov 01; 440(4):646-51. PubMed ID: 24103752 [Abstract] [Full Text] [Related]
16. [A case of antimony resistant kala-azar cured with amphotericin B]. Chen SB, Yang CM, Zhang CJ. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Jun 01; 25(3):inside front page. PubMed ID: 18038767 [No Abstract] [Full Text] [Related]
17. Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani. Lira R, Sundar S, Makharia A, Kenney R, Gam A, Saraiva E, Sacks D. J Infect Dis; 1999 Aug 01; 180(2):564-7. PubMed ID: 10395884 [Abstract] [Full Text] [Related]
18. Leishmania donovani vs immunity: T-cells sensitized from Leishmania of one donor may modulate their cytokines pattern on re-stimulation with Leishmania from different donor in visceral leishmaniasis. Narayan S, Bimal S, Singh SK, Gupta AK, Singh VP, Sinha PK, Das P. Exp Parasitol; 2009 Jan 01; 121(1):69-75. PubMed ID: 18948098 [Abstract] [Full Text] [Related]
19. Integrative genomic, proteomic and phenotypic studies of Leishmania donovani strains revealed genetic features associated with virulence and antimony-resistance. Zheng Z, Chen J, Ma G, Satoskar AR, Li J. Parasit Vectors; 2020 Oct 12; 13(1):510. PubMed ID: 33046138 [Abstract] [Full Text] [Related]
20. Increased metacyclogenesis of antimony-resistant Leishmania donovani clinical lines. Ouakad M, Vanaerschot M, Rijal S, Sundar S, Speybroeck N, Kestens L, Boel L, De Doncker S, Maes I, Decuypere S, Dujardin JC. Parasitology; 2011 Sep 12; 138(11):1392-9. PubMed ID: 21819638 [Abstract] [Full Text] [Related] Page: [Next] [New Search]